相似文献
1
Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1.
Nephrol Dial Transplant. 2010 May;25(5):1708-13. doi: 10.1093/ndt/gfp693. Epub 2010 Jan 12.
2
Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases.
Sci Rep. 2020 Aug 20;10(1):14026. doi: 10.1038/s41598-020-71101-y.
3
IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
Kidney Int. 2018 Mar;93(3):700-705. doi: 10.1016/j.kint.2017.10.019. Epub 2018 Jan 10.
4
Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
Clin Immunol. 2020 Aug;217:108483. doi: 10.1016/j.clim.2020.108483. Epub 2020 May 30.
5
Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy.
PLoS One. 2018 Nov 2;13(11):e0206865. doi: 10.1371/journal.pone.0206865. eCollection 2018.
6
Association Between Galactose-Deficient IgA1 Derived From the Tonsils and Recurrence of IgA Nephropathy in Patients Who Underwent Kidney Transplantation.
Front Immunol. 2020 Sep 3;11:2068. doi: 10.3389/fimmu.2020.02068. eCollection 2020.
7
Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
Dis Markers. 2016;2016:7806438. doi: 10.1155/2016/7806438. Epub 2016 Aug 28.
8
Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression.
BMC Nephrol. 2023 Jun 7;24(1):160. doi: 10.1186/s12882-023-03198-y.
9
A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy.
Transplant Proc. 2017 Apr;49(3):541-545. doi: 10.1016/j.transproceed.2017.02.003.
10
Glomerular Immunodeposits of Patients with IgA Nephropathy Are Enriched for IgG Autoantibodies Specific for Galactose-Deficient IgA1.
J Am Soc Nephrol. 2019 Oct;30(10):2017-2026. doi: 10.1681/ASN.2018111156. Epub 2019 Aug 23.
引用本文的文献
1
Clinical Manifestations and Prognosis of Chronic Kidney Disease after Hematopoietic Stem Cell Transplantation.
Kidney Dis (Basel). 2025 Mar 12;11(1):195-205. doi: 10.1159/000545198. eCollection 2025 Jan-Dec.
2
Minimal Change Disease Secondary to Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplant for Myelodysplastic Syndrome.
Case Rep Nephrol Dial. 2022 Mar 14;12(1):31-37. doi: 10.1159/000522333. eCollection 2022 Jan-Apr.
3
Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don't Know.
J Clin Med. 2021 Aug 5;10(16):3467. doi: 10.3390/jcm10163467.
4
Mini-review of kidney disease following hematopoietic stem cell transplant
.
Clin Nephrol. 2018 Jun;89(6):389-402. doi: 10.5414/CN109276.
5
Renal pathology in hematopoietic cell transplant recipients: a contemporary biopsy, nephrectomy, and autopsy series.
Mod Pathol. 2016 Jun;29(6):637-52. doi: 10.1038/modpathol.2016.61. Epub 2016 Mar 25.
6
Sequential therapy with cyclophosphamide and mycophenolic acid in patients with progressive immunoglobulin A nephropathy: a long-term follow-up.
Clin Exp Immunol. 2016 Feb;183(2):307-16. doi: 10.1111/cei.12719. Epub 2015 Nov 26.
7
Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy.
PLoS One. 2014 Feb 21;9(2):e89707. doi: 10.1371/journal.pone.0089707. eCollection 2014.
本文引用的文献
1
Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?
Clin J Am Soc Nephrol. 2006 Jul;1(4):685-94. doi: 10.2215/CJN.00380705. Epub 2006 Mar 15.
2
Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells.
Kidney Int. 2007 Aug;72(3):319-27. doi: 10.1038/sj.ki.5002300. Epub 2007 May 9.
3
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels.
Kidney Int. 2007 Jun;71(11):1148-54. doi: 10.1038/sj.ki.5002185. Epub 2007 Mar 7.
4
Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment.
J Am Soc Nephrol. 2006 Jul;17(7):1995-2005. doi: 10.1681/ASN.2006020118. Epub 2006 May 24.
5
Renal involvement in bone marrow transplantation.
Nephrology (Carlton). 2005 Oct;10(5):530-6. doi: 10.1111/j.1440-1797.2005.00478.x.
6
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
Kidney Int. 2005 Feb;67(2):504-13. doi: 10.1111/j.1523-1755.2005.67107.x.
7
IgA nephropathy complicating graft-versus-host disease, another nephropathy causing nephrotic syndrome after bone marrow transplantation.
Histopathology. 2004 Dec;45(6):648-51. doi: 10.1111/j.1365-2559.2004.01958.x.
8
Roles of bone marrow cells in glomerular diseases.
Clin Exp Nephrol. 2003 Sep;7(3):179-85. doi: 10.1007/s10157-003-0248-9.
9
Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma.
Blood. 2003 May 15;101(10):4219-21. doi: 10.1182/blood-2002-07-2290. Epub 2003 Jan 23.
10
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
J Clin Invest. 1999 Jul;104(1):73-81. doi: 10.1172/JCI5535.
Zotero 插件